USP 797 is a sterile compounding preparation standard for pharmacies designed to reduce the transmission of infections to patients and control exposure to pharmacy workers. It is being promulgated to insure contamination free compounding. As part of a larger infection control program, the standard demands strict evaluation and testing of the hospital environment. The guidelines of USP 797 call for changes in the pharmaceutical compounding of sterile preparations in health-care institutions. RJLG’s experts are nationally recognized as leaders in contaminant assessment and analytical testing.
We execute the "Formula for Compliance" to meet the new standards and long-term procedures to manage the process.
| Environmental Monitoring |
Baseline monitoring in a health care environment is critical to detect adverse trends in contamination populations and to track problems. RJLG performs all environmental monitoring for microbials and particulate that are necessary to meet the requirements outlined by USP chapter 797. Monitoring can also be conformed to ensure compliance with OSHA regulations. Monitoring is performed either as part of a "pre-construction" assessment or a "pre-turnover" assessment. RJLG uses state of the art methods for environmental monitoring. |
 |
|||
|
|||
